CTOs on the Move

MJS BioLynx

www.biolynx.ca

 
MJS BioLynx Inc. is a Brockville, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.biolynx.ca
  • PO Bag 1150 300 Laurier Blvd
    Brockville, ON CAN K6V 5W1
  • Phone: 613.498.2126

Executives

Name Title Contact Details

Similar Companies

INNOVATIVE MEDICAL MANUFACTURING

INNOVATIVE MEDICAL MANUFACTURING is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

InstaMed

InstaMed is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Noctrix Health

Noctrix Health is a pioneer in developing the next-generation of wearable therapeutics. Backed by scientific evidence and clinical data, we aim to make prescription-grade medical devices accessible so physicians and patients have more choices beyond the pill. Stay tuned for updates.

Surmodics

Surmodics partners with the world`s leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. Following two recent acquisitions, the company is transforming its medical device business from being a provider of coating technologies, to offering whole-product solutions. Throughout its transformation, Surmodics` mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges

Lensar

LENSAR, Inc. is a global leader in next-generation femtosecond laser technology for refractive cataract surgery. The LENSAR Laser System offers cataract surgeons precision, accuracy, and efficiency while optimizing overall visual outcomes. LENSAR`s proprietary Augmented Reality technology -- reconstructed 3-D imaging, measurement, and guidance system -- offers quick and easy patient docking and provides high-resolution ocular images in a single scan. This technology facilitates enhanced procedure outcomes by allowing the physician to develop individualized treatment plans including precise laser delivery, and efficient lens fragmentation that can reduce, and potentially eliminate phaco energy. The LENSAR Laser System also offers the industry`s smallest laser footprint and thoughtful ergonomic design that accommodates most operating rooms. The LENSAR Laser System has been cleared by FDA for anterior capsulotomy, lens fragmentation, and corneal and arcuate incisions. For other indications it is an investigational device limited by U.S. law to investigational use only